Mono Pharmacare Ltd. - Research Center
Group () BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | |
|---|---|---|
| Sales | 34.60 | 23.45 |
| Operating profit | 2.04 | 0.98 |
| Interest | 0.58 | 0.37 |
| Gross profit | 2.24 | 0.68 |
| EPS (Rs) | 1.06 | 0.48 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | |
|---|---|---|
| Other income | 0.78 | 0.07 |
| Stock adjustment | -4.51 | -2.18 |
| Raw material | - | - |
| Power and fuel | - | - |
| Employee expenses | 1.06 | 0.22 |
| Excise | - | - |
| Admin and selling expenses | - | - |
| Research and development expenses | - | - |
| Expenses capitalised | - | - |
| Other expenses | 36.01 | 24.42 |
| Provisions made | - | - |
| Depreciation | 0.04 | 0.03 |
| Taxation | 0.34 | 0.05 |
| Net profit / loss | 1.87 | 0.60 |
| Extra ordinary item | - | - |
| Prior year adjustments | - | - |
| Equity capital | 17.67 | 12.37 |
| Equity dividend rate | - | - |
| Agg.of non-prom. shares (Lacs) | - | - |
| Agg.of non promotoholding (%) | - | - |
| OPM (%) | 5.89 | 4.19 |
| GPM (%) | 6.33 | 2.89 |
| NPM (%) | 5.27 | 2.53 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis